FDA Releases Naloxone Drug Facts Labels to Spur OTC Development

By Sam | February 5, 2019

FDA Commissioner Scott Gottlieb announced that the agency has developed easy-to-understand model drug facts labels (DFLs) to encourage drugmakers to develop an OTC version of the opioid overdose treatment naloxone.
Source: Drug GMP Report

Posted in Drug GMP Report